As of January 22, 2025, Praxis Precision Medicines (PRAX) has a market cap of $1.48 billion USD. According to our data, Praxis Precision Medicines is ranked No.4605 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $1.48 B |
3.42%
|
Dec 31, 2024 | $1.43 B |
245.42%
|
Dec 29, 2023 | $0.42 B |
-37.59%
|
Dec 30, 2022 | $0.67 B |
-87.92%
|
Dec 31, 2021 | $5.51 B |
-64.19%
|
Dec 31, 2020 | $15.38 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Sage Therapeutics
SAGE
|
$0.43 B |
-0.000 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Eli Lilly
LLY
|
$677.80 B |
-0.006 M
|
USA
|
Neurocrine Biosciences
NBIX
|
$14.86 B |
-0.000 M
|
USA
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
Alkermes
ALKS
|
$4.89 B |
-0.000 M
|
Ireland
|
Myriad Genetics
MYGN
|
$1.12 B |
-0.000 M
|
USA
|
Geron
GERN
|
$1.81 B |
-0.000 M
|
USA
|
Omeros Corporation
OMER
|
$0.54 B |
0.000 M
|
USA
|
Cassava Sciences
SAVA
|
$0.12 B |
0.000 M
|
USA
|
Rhythm Pharmaceuticals
RYTM
|
$3.52 B |
0.000 M
|
USA
|
Taysha Gene Therapies
TSHA
|
$0.31 B |
-0.000 M
|
USA
|
Market Cap | = | PRAX Stock Price | * | PRAX Shares Outstanding |
= | $79.59 | * | 18.64 M | |
= | $1.48 B |